18
Mar
2013

Time to cut pharmaceutical prices and end Australia’s bad drug deal

by Stephen Duckett


The Australian Pharmaceutical Benefits Scheme is wasting more than $1 million a day on excessively high prices for prescription drugs, especially generic drugs. The Commonwealth should follow New Zealand’s example and get tough with global drug companies. Here’s how.